Alyx Rosen

749 total citations
19 papers, 507 citations indexed

About

Alyx Rosen is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, Alyx Rosen has authored 19 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Dermatology. Recurrent topics in Alyx Rosen's work include Colorectal Cancer Treatments and Studies (6 papers), Melanoma and MAPK Pathways (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Alyx Rosen is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Melanoma and MAPK Pathways (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Alyx Rosen collaborates with scholars based in United States, Brazil and Colombia. Alyx Rosen's co-authors include Mario E. Lacouture, Shenhong Wu, Yevgeniy Balagula, Dennis P. West, Stephen W. Dusza, Jennifer Gordon, Eric J. Sherman, Nicole Larsen, Milan J. Anadkat and Wasif N. Khan and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

Alyx Rosen

18 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alyx Rosen United States 12 274 174 130 111 70 19 507
Hitoe Torisu‐Itakura United States 15 256 0.9× 199 1.1× 119 0.9× 90 0.8× 20 0.3× 35 619
Nora Ratcliffe United States 10 96 0.4× 60 0.3× 77 0.6× 122 1.1× 36 0.5× 21 443
C. De Gislain France 9 137 0.5× 141 0.8× 61 0.5× 25 0.2× 116 1.7× 15 441
Mandeep S. Dhami United States 3 302 1.1× 52 0.3× 34 0.3× 36 0.3× 39 0.6× 5 387
Parita Soni United States 7 459 1.7× 20 0.1× 46 0.4× 86 0.8× 118 1.7× 17 553
Eitan Giat Israel 7 149 0.5× 19 0.1× 210 1.6× 52 0.5× 49 0.7× 14 487
Hiroto Horiguchi Japan 9 124 0.5× 61 0.4× 99 0.8× 13 0.1× 59 0.8× 29 336
Bogdan Fetică Romania 10 151 0.6× 18 0.1× 119 0.9× 38 0.3× 50 0.7× 58 441
Remco van Dijk Netherlands 11 145 0.5× 135 0.8× 146 1.1× 110 1.0× 32 0.5× 19 564
Grażyna Wróbel Poland 11 179 0.7× 32 0.2× 73 0.6× 23 0.2× 111 1.6× 29 551

Countries citing papers authored by Alyx Rosen

Since Specialization
Citations

This map shows the geographic impact of Alyx Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alyx Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alyx Rosen more than expected).

Fields of papers citing papers by Alyx Rosen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alyx Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alyx Rosen. The network helps show where Alyx Rosen may publish in the future.

Co-authorship network of co-authors of Alyx Rosen

This figure shows the co-authorship network connecting the top 25 collaborators of Alyx Rosen. A scholar is included among the top collaborators of Alyx Rosen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alyx Rosen. Alyx Rosen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cervantes, Jessica, Alyx Rosen, Luis Dehesa, Gordon M. Dickinson, & Javier Alonso‐Llamazares. (2018). Reacción granulomatosa en paciente con melanoma metastásico tratado con ipilimumab: primer caso descrito presentando clínica cutánea únicamente. Actas Dermo-Sifiliográficas. 110(1). 43–49. 11 indexed citations
2.
Cervantes, Jessica, Alyx Rosen, Luis Dehesa, Gordon M. Dickinson, & Javier Alonso‐Llamazares. (2018). Granulomatous Reaction in a Patient With Metastatic Melanoma Treated With Ipilimumab: First Case Reported With Isolated Cutaneous Findings. Actas Dermo-Sifiliográficas. 110(1). 43–49. 9 indexed citations
3.
Nichols, Anna, Emily S. Clark, Wasif N. Khan, et al.. (2018). Combined Systemic and Intratumoral Administration of Human Papillomavirus Vaccine to Treat Multiple Cutaneous Basaloid Squamous Cell Carcinomas. JAMA Dermatology. 154(8). 927–927. 53 indexed citations
4.
Rosen, Alyx, et al.. (2017). Post-reconstruction dermatitis of the breast. Journal of Plastic Reconstructive & Aesthetic Surgery. 70(10). 1369–1376. 3 indexed citations
5.
6.
Rosen, Alyx, et al.. (2016). Allergic contact cheilitis in children and improvement with patch testing. JAAD Case Reports. 3(1). 25–28. 1 indexed citations
7.
Aldahan, Adam S., Alyx Rosen, & Shasa Hu. (2016). A Large Verrucous Plaque on the Calf. JAMA Dermatology. 152(11). 1269–1269. 1 indexed citations
8.
Belum, Viswanath Reddy, Alyx Rosen, Natalia Jaimes, et al.. (2014). Clinico‐morphological features of BRAF inhibition–induced proliferative skin lesions in cancer patients. Cancer. 121(1). 60–68. 15 indexed citations
9.
Rosen, Alyx, Yevgeniy Balagula, Dennis W. Raisch, et al.. (2013). Life-threatening dermatologic adverse events in oncology. Anti-Cancer Drugs. 25(2). 225–234. 49 indexed citations
10.
Rosen, Alyx, et al.. (2013). Pruritus in patients treated with targeted cancer therapies: Systematic review and meta-analysis. Journal of the American Academy of Dermatology. 69(5). 708–720. 70 indexed citations
11.
Rosen, Alyx, Stephen W. Dusza, Yevgeniy Balagula, et al.. (2013). Impact of Dermatologic Adverse Events on Quality of Life in 283 Cancer Patients: A Questionnaire Study in a Dermatology Referral Clinic. American Journal of Clinical Dermatology. 14(4). 327–333. 122 indexed citations
12.
Rosen, Alyx, et al.. (2013). Pruritus to anticancer agents targeting the EGFR, BRAF, and CTLA-4. Dermatologic Therapy. 26(2). 135–148. 34 indexed citations
13.
Rosen, Alyx, et al.. (2013). Pruritus in patients treated with targeted cancer therapies: Systematic review and meta-analysis.. Journal of Clinical Oncology. 31(15_suppl). e13571–e13571. 1 indexed citations
14.
Rosen, Alyx, et al.. (2012). Risk of Rash in Cancer Patients Treated with Vandetanib: Systematic Review and Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism. 97(4). 1125–1133. 42 indexed citations
15.
Ramirez‐Fort, Marigdalia K., et al.. (2012). Rash to the mTOR Inhibitor Everolimus. American Journal of Clinical Oncology. 37(3). 266–271. 23 indexed citations
16.
Balagula, Yevgeniy, Alyx Rosen, Belinda H. Tan, et al.. (2012). Clinical and histopathologic characteristics of rash in cancer patients treated with mammalian target of rapamycin inhibitors. Cancer. 118(20). 5078–5083. 28 indexed citations
17.
Ramirez‐Fort, Marigdalia K., et al.. (2012). Rash to mTOR inhibitor everolimus: Systematic review and meta-analysis.. Journal of Clinical Oncology. 30(15_suppl). e19624–e19624. 7 indexed citations
18.
Gavrilovic, Igor T., Yevgeniy Balagula, Alyx Rosen, et al.. (2012). Characteristics of Oral Mucosal Events Related to Bevacizumab Treatment. The Oncologist. 17(2). 274–278. 24 indexed citations
19.
Holland, Kristen E., et al.. (1982). Lymphocytapheresis in multiple sclerosis: a preliminary report.. PubMed. 106. 255–62. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026